Literature DB >> 25080518

Prefrontal involvement related to cognitive impairment in progressive muscular atrophy.

Joost Raaphorst1, Marie-José van Tol2, Paul F C Groot2, Ellemarije Altena2, Ysbrand D van der Werf2, Charles B Majoie2, Anneke J van der Kooi2, Leonard H van den Berg2, Ben Schmand2, Marianne de Visser2, Dick J Veltman2.   

Abstract

OBJECTIVE: To examine brain activation patterns during verbal fluency performance in patients with progressive muscular atrophy (PMA) and amyotrophic lateral sclerosis (ALS).
METHODS: fMRI was used to examine the blood oxygen level-dependent response during letter and category fluency performance in 18 patients with PMA, 21 patients with ALS, and 17 healthy control subjects, matched for age and education. fMRI results are reported at p<0.05, family-wise error (FWE)-corrected for multiple comparisons. We analyzed effects of performance, age-related white matter changes (ARWMC), and regional brain volumes; all participants underwent neuropsychological investigation.
RESULTS: Disease duration of patients with PMA (mean 26.0 months, SD 13.6) and ALS (22.2 months, SD 11.4) was comparable. Patients with PMA and ALS had mild to moderate disease severity and showed impaired letter fluency compared with controls. Between-group analysis showed a main effect of group in the left inferior frontal gyrus (IFG, Brodmann area 45) during letter fluency, which was unaffected by performance, ARWMC, and IFG volume: patients with PMA showed lower activation than controls but higher than that of patients with ALS (ALS<PMA<healthy controls; pFWE=0.035; z score 4.11; cluster size=11). A more caudal region in the IFG showed lower activation in patients with PMA than controls during letter fluency performance (post hoc test; pFWE=0.026). No activation differences were observed during the category fluency task.
CONCLUSION: Prefrontal activation abnormalities are related to an important clinical measure of executive dysfunction in patients with motor neuron disease with and without upper motor neuron signs.
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Year:  2014        PMID: 25080518     DOI: 10.1212/WNL.0000000000000745

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Brain MRI shows white matter sparing in Kennedy's disease and slow-progressing lower motor neuron disease.

Authors:  Edoardo G Spinelli; Federica Agosta; Pilar M Ferraro; Giorgia Querin; Nilo Riva; Cinzia Bertolin; Ilaria Martinelli; Christian Lunetta; Andrea Fontana; Gianni Sorarù; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2019-03-28       Impact factor: 5.038

Review 2.  Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis.

Authors:  Esther Verstraete; Bradley R Foerster
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

3.  Neuropsychological investigation in Chinese patients with progressive muscular atrophy.

Authors:  Bo Cui; Liying Cui; Mingsheng Liu; Xiaoguang Li; Junfang Ma; Jia Fang; Qingyun Ding
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

Review 4.  What does imaging reveal about the pathology of amyotrophic lateral sclerosis?

Authors:  Martin R Turner; Esther Verstraete
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

5.  Classification of amyotrophic lateral sclerosis by brain volume, connectivity, and network dynamics.

Authors:  Janine Thome; Robert Steinbach; Julian Grosskreutz; Daniel Durstewitz; Georgia Koppe
Journal:  Hum Brain Mapp       Date:  2021-10-16       Impact factor: 5.038

6.  Voxel-Wise Meta-Analysis of Gray Matter Changes in Amyotrophic Lateral Sclerosis.

Authors:  Dongchao Shen; Liying Cui; Jia Fang; Bo Cui; Dawei Li; Hongfei Tai
Journal:  Front Aging Neurosci       Date:  2016-03-30       Impact factor: 5.750

7.  A Systematic Review and Meta-Analysis of the Functional MRI Investigation of Motor Neuron Disease.

Authors:  Dongchao Shen; Liying Cui; Bo Cui; Jia Fang; Dawei Li; Junfang Ma
Journal:  Front Neurol       Date:  2015-11-24       Impact factor: 4.003

Review 8.  Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis.

Authors:  Ricarda A L Menke; Federica Agosta; Julian Grosskreutz; Massimo Filippi; Martin R Turner
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.